Preparation of Androstanes Related to Aphidicolin
1551
5α-An drosta-2,16-dien e (17)
Un der sim ilar con dition s th e iodoalken e 16 (250 m g, 0.6 m m ol) gave th e dien e 17 (135 m g,
80.5%) as an oil. IR: 1640 (C=C). 1H NMR (300 MHz, CDCl3): 0.78 s, 3 H (H-18); 0.80 s, 3 H
(H-19); 5.56 m , 2 H (H-2 an d H-3); 5.69 d, 1 H, J(17,16) = 4.7 (H-17); 5.84 dd, 1 H, J(16,15) =
1.8, J(16,17) = 4.7 (H-16). 13C NMR (75 MHz, CDCl3): 143.9, 129.2, 125.9 (2 × C); 56.1, 54.8,
45.5, 41.6, 39.6, 35.9, 34.9, 34.2, 31.9, 31.8, 30.3, 28.7, 20.8, 17.0, 11.6. HRMS: for C19H28
calculated: 256.2195; foun d: 256.2200.
5α-An drostan e-3α,4α,17β-triol (5)
5α-An drost-3-en -17β-ol8 (4; 140 m g, 0.5 m m ol) in tert-butan ol (15 m l) an d water (15 m l)
was treated with potassium h exacyan oferrate(III) (1.65 g, 5 m m ol), potassium carbon ate
(690 m g, 5 m m ol), 1,4-diazobicyclo[2,2,2]octan e (56 m g, 0.5 m m ol) an d th e stock solution
of osm ium tetraoxide (0.4 m l) at 40 °C for 24 h . Sodium sulfite (140 m g, 1.1 m m ol) was
added an d th e solution was th en left to stir overn igh t. Th e m ixture was filtered an d ex-
tracted with eth yl acetate. Th e extract was dried an d th e solven t was evaporated to give th e
triol 5 (104 m g, 71%) wh ich was crystallized from eth yl acetate as n eedles, m .p. 194–196 °C.
For C19H32O3 (308.5) calculated: 74.00% C, 10.52% H; foun d: 73.65% C, 10.37% H. IR: 3490
(O-H). 1H NMR (500 MHz, pyridin e-d5): 0. 87 s, 3 H (H-18); 0.96 s, 3 H (H-19); 3.69 dd, 1 H,
J = 3.0, 11.0 (H-4); 3.83 t, 1 H, J = 8.5 (H-17); 4.28 q, 1 H, J = 3.0 (H-3). 13C NMR (100 MHz,
pyridin e-d5): 80.6, 71.1, 69.4, 55.2, 50.7, 45.4, 42.7, 36.9, 36.8, 34.8, 31.6, 31.1, 29.9, 27.3,
23.0, 22.5, 20.2, 12.3, 11.3. Th e triacetate 6, prepared with acetic an h ydride in pyridin e, h ad
m .p. 184–186 °C. IR: 1745 (C=O, acetate), 1716 (C=O, acetate). 1H NMR (300 MHz, CDCl3):
0.75 s, 3 H (H-18); 0.85 s, 3 H (H-19); 1.96 s, 3 H (17β-OAc); 2.0 s, 3 H (4α-OAc); 2.06 s, 3 H
(3α-OAc); 4.5 t, 1 H, J = 8.5 (H-17); 4.7 dd, 1 H, J = 3.0, 11.0 (H-4); 5.22 q, 1 H, J = 3.0 (H-3).
13C NMR (75 MHz, CDCl3): 171.65, 171.17, 170.89, 83.15, 72.71, 69.67, 54.49, 51.11, 44.22,
42.89, 37.89, 37.21, 35.17, 32.34, 31.13, 27.89, 25.61, 23.81, 22.65, 21.65, 21.57, 21.34,
20.71, 13.09, 12.50. HRMS: for C25H38O6 + Na calculated: 457.2560; foun d: 457.2562.
5α-An drostan e-3α,4α,16α,17α-tetrol (11)
Un der sim ilar con dition s th e dien e 10 (130 m g, 0.5 m m ol) gave th e tetrol 11 (100 m g, 61%)
as a wh ite powder, m .p. 234–236 °C. For C19H32O4·0.5H2O (333.5) calculated 68.41% C,
10.00% H; foun d: 68.37% C, 9.95% H. IR: 3470 broad (O-H). 1H NMR (500 MHz,
pyridin e-d5): 0. 70 s, 3 H (H-18); 0.85 s, 3 H (H-19); 3.67 dd, 1 H, J = 3.0, 11.0 (H-4); 3.82 d,
1 H, J = 5.3 (H-17); 4.28 q, 1 H, J = 3.0 (H-3); 4.67 q, 1 H, J = 5.3 (H-16). 13C NMR (100 MHz,
pyridin e-d5): 78.9, 71.6, 71.3, 69.7, 54.6, 47.6, 46.2, 45.2, 37.5, 36.1, 35.5, 32.6, 32.3, 32.1,
28.1, 23.4, 20.3, 17.5, 12.9.
5α-An drostan e-2α,3α,16α,17α-tetrol (18)
Un der sim ilar con dition s th e dien e 17 (130 m g, 0.5 m m ol) gave th e tetrol 18 (90 m g, 55%)
as a wh ite powder, m .p. 220–223 °C. IR: 3450 broad (O-H). 1H NMR (500 MHz, pyridin e-d5):
0.67 s, 3 H (H-18); 0.82 s, 3 H (H-19); 3.82 d, 1 H, J(16,17) = 5.0 (H-17); 4.01 m , 1 H (H-2);
4.30 q, 1 H, J = 3.0 (H-3); 4.67 m , 1 H (H-16). 13C NMR (100 MHz, pyridin e-d5): 78.9, 71.6,
71.2, 69.8, 54.7, 47.6, 45.6, 41.0, 39.8, 36.3, 36.1, 35.7, 32.6, 32.3, 30.8, 28.2, 20.3, 18.1,
12.9. HRMS: for C19H32O4 calculated: 324.2301; foun d: 324.2298.
Collect. Czech. Chem. Commun. 2007, Vol. 72, No. 11, pp. 1545–1552